Business Description
Revelation Biosciences Inc
NAICS : 541715
SIC : 2834
ISIN : US76135L5075
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.54 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 12.22 | |||||
9-Day RSI | 18.29 | |||||
14-Day RSI | 23.87 | |||||
6-1 Month Momentum % | -48.97 | |||||
12-1 Month Momentum % | -72.59 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.18 | |||||
Quick Ratio | 2.18 | |||||
Cash Ratio | 2.15 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -394.1 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -1.58 | |||||
ROA % | -0.91 | |||||
ROIC % | -226.52 | |||||
ROC (Joel Greenblatt) % | -11155.93 | |||||
ROCE % | -114.05 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 0.07 | |||||
PB Ratio | 0.09 | |||||
Price-to-Tangible-Book | 0.09 | |||||
EV-to-EBIT | -1.13 | |||||
EV-to-EBITDA | -1.13 | |||||
EV-to-FCF | -1.34 | |||||
Price-to-Net-Current-Asset-Value | 0.09 | |||||
Price-to-Net-Cash | 0.09 | |||||
Earnings Yield (Greenblatt) % | -88.5 | |||||
FCF Yield % | -204.69 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Revelation Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | 28.554 | ||
Beta | 0 | ||
Volatility % | 47.98 | ||
14-Day RSI | 23.87 | ||
14-Day ATR (€) | 0.003978 | ||
20-Day SMA (€) | 8.88 | ||
12-1 Month Momentum % | -72.59 | ||
52-Week Range (€) | 8.88 - 34.5 | ||
Shares Outstanding (Mil) | 1.63 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Revelation Biosciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Revelation Biosciences Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Revelation Biosciences Inc Frequently Asked Questions
What is Revelation Biosciences Inc(FRA:56U0)'s stock price today?
When is next earnings date of Revelation Biosciences Inc(FRA:56U0)?
Does Revelation Biosciences Inc(FRA:56U0) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |